Integrity Advisory’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$140K	Sell	17,109 -15,977	-48%	-$131K	0.13%	73
2022 Q3	$192K	Buy	33,086 +18,824	+132%	+$109K	0.18%	70
2022 Q2	$63K	Buy	14,262 +2,991	+27%	+$13.2K	0.06%	69
2022 Q1	$103K	Buy	+11,271	New	+$103K	0.1%	77